Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?

Gorcenco, Sorina LU ; Vaz, Frédéric M. ; Tracewska-Siemiatkowska, Anna ; Tranebjærg, Lisbeth ; Cremers, Frans P.M. ; Ygland, Emil LU ; Kicsi, Jenő ; Rendtorff, Nanna Dahl ; Möller, Claes and Kjellström, Ulrika LU , et al. (2019) In Parkinsonism & Related Disorders 61. p.245-247
Please use this url to cite or link to this publication:
@article{52ba4849-9c48-42f9-98e4-d655b2fdd48c,
  author       = {{Gorcenco, Sorina and Vaz, Frédéric M. and Tracewska-Siemiatkowska, Anna and Tranebjærg, Lisbeth and Cremers, Frans P.M. and Ygland, Emil and Kicsi, Jenő and Rendtorff, Nanna Dahl and Möller, Claes and Kjellström, Ulrika and Andréasson, Sten and Puschmann, Andreas}},
  issn         = {{1873-5126}},
  keywords     = {{Adult; Ataxia; Brown-Vialetto-Van Laere syndrome-2; BVVLS2; Pharmacokinetics; Recessive; Riboflavin transporter deficiency; SLC52A2; Treatment}},
  language     = {{eng}},
  pages        = {{245--247}},
  publisher    = {{Elsevier}},
  series       = {{Parkinsonism & Related Disorders}},
  title        = {{Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?}},
  url          = {{http://dx.doi.org/10.1016/j.parkreldis.2018.10.017}},
  doi          = {{10.1016/j.parkreldis.2018.10.017}},
  volume       = {{61}},
  year         = {{2019}},
}